Max Thompson
Mater Research Institute, QLD, Australia
- This delegate is presenting an abstract at this event.
PhD Candidate at Mater Research with Tumour Biology and Therapeutics Research (K. K. Khanna Laboratory).
Presentations this author is a contributor to:
CHK1 inhibitor with low dose Hydroxyurea Amplifies Replication Stress and Drives a Novel Pan-nuclear Ataxia Telangiectasia Mutated Phenotype (#261)
5:35 PM
Max J Thompson
Poster Session 2
CANCER 2026